欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/2807/001
药品名称Moxifloxacine Fresenius Kabi 400 mg/250 ml solution for infustion
活性成分
    • Moxifloxacin hydrochloride 400.0 mg/250 ml
剂型Solution for infusion
上市许可持有人Fresenius Kabi Nederland BV Molenberglei 7, 2627 Schelle Belgium
参考成员国 - 产品名称Netherlands (NL)
Moxifloxacine Fresenius Kabi 400 mg/ 260 ml oplossing voor infusie
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Luxembourg (LU)
    • Ireland (IE)
    • Austria (AT)
    • Spain (ES)
    • Sweden (SE)
    • Finland (FI)
    • Hungary (HU)
    • Bulgaria (BG)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
许可日期2013/11/27
最近更新日期2025/01/21
药物ATC编码
    • J01MA14 moxifloxacin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase